Alis volat propriis
She flies with her own wings
FAST VETS Act
The bill increases veterans' control and the likelihood of better employment outcomes by requiring collaborative, updated individualized plans, but it raises administrative costs for the VA and risks delays or interruptions in services when redevelopments are disapproved.
Stop Musk Act
The bill strengthens protections for federal employees who refuse or report directives they view as unlawful—immediately boosting integrity and recourse—but risks new legal disputes, supervisory complications, and perceptions of politicized or unequal protections.
VHA OPEN Policies Act of 2026
The bill increases transparency and quicker policy access for veterans, clinicians, and the public, but does so at the cost of added administrative burden, potential redaction work, and taxpayer-funded implementation.
Dignity and Due Process for Children Act of 2026
The bill strengthens due-process and legal-access protections for unaccompanied immigrant children, but does so at the cost of added administrative requirements, potential slower enforcement response in some large-scale operations, and higher legal service costs.
MEDIC Careers Act of 2026
The bill helps separating service members transition into civilian healthcare and modestly boosts staffing in underserved areas through credential alignment and pilot grants, but its impact is constrained by relatively small funding, eligibility limits, and implementation costs and uncertainties for states and the Department of Defense.
Dietary Supplement Listing Act of 2026
The bill increases consumer transparency and FDA oversight of dietary supplements through a public product‑listing database and dedicated funding, while imposing new compliance burdens and some disclosure and fiscal costs on manufacturers and taxpayers.
Plug Offshore Wells Act
The bill increases public and regulatory transparency and enforcement accountability around offshore decommissioning—helping communities and environmental oversight—while imposing modest taxpayer-funded administrative costs, potential commercial harms to operators, and a two-year wait before the first report.
Protecting Americans from Unsafe Drugs Act of 2026
The bill strengthens FDA and customs authority to keep unsafe imported drugs out of U.S. markets—improving public health protection and enforcement clarity—but does so at the cost of higher compliance burdens, potential delays or reduced access to some imported therapies, and increased scope for administrative discretion.
Modernize SSI Stipends Act
The bill substantially increases and protects the monthly personal needs allowance for institutionalized SSI recipients—boosting immediate and long‑term purchasing power—while imposing higher federal/state costs and implementation burdens that governments must absorb or offset.
Better Care for PFAS Patients Act of 2026
The bill provides timely, science-based PFAS clinical guidance and community input to improve detection and care, but does so at the cost of added implementation expenses for health systems and administrative/funding burdens and carries a risk of delays in delivering guidance.